PMV Pharmaceuticals Lands $30,000,000 Series A Financing
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=10bbd273-801a-48d3-a796-ca6f21bb8bfd - Date
12/3/2014 - Company Name
PMV Pharmaceuticals - Mailing Address
497 Seaport Court Redwood City, CA 94063 USA - Company Description
PMV Pharmaceuticals is developing first-in-class p53 and p53 pathway modulators for the treatment of cancer. Bringing together leaders in the field to utilize over three decades of p53 biology, PMV combines unique biological understanding with pharmaceutical development focus. - Website
http://www.pmvpharma.com - Transaction Type
Venture Equity - Transaction Amount
$30,000,000 - Transaction Round
Series A - Proceeds Purposes
The proceeds of this financing will support the advancement of the Company’s rapidly emerging pipeline of p53 focused therapeutics. - M&A Terms
- Venture Investor
- Venture Investor
- Venture Investor
